Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.
about
Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionManagement of HBV Infection in Liver Transplantation PatientsSuccessful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutantKASL clinical practice guidelines: management of chronic hepatitis BAntiviral drug resistance: mechanisms and clinical implicationsClinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxilTwo-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentAntiviral therapy and resistance with hepatitis B virus infection.A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assemblyAntiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis BComplex dynamics of hepatitis B virus resistance to adefovir.Antiviral treatment of chronic hepatitis B virus (HBV) infectionsTh1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon.Virological response to adefovir monotherapy and the risk of adefovir resistanceHBV and HCV therapy.Emerging drugs for hepatitis B.Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue TherapyInhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.Entecavir for the treatment of chronic hepatitis B.Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.Complications in treating chronic hepatitis B in patients with HIV.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesReview article: hepatitis B and liver transplantation.Antiviral therapies: focus on hepatitis B reverse transcriptaseEvolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyRecurrence of diseases following orthotopic liver transplantation.Treatment options for chronic hepatitis B and C infection in children.Prevention of hepatitis B virus recurrence after liver transplantation.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.Management of chronic hepatitis B: consensus guidelinesLamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
P2860
Q24187530-F6558C8B-24E3-492D-AE0F-01264E3FE3E1Q24529103-7FDC4100-0A12-40A2-9211-C175F73D1F4FQ25256648-E5A6575B-0A5B-4292-BADC-3763EA9CE922Q26752475-3F36CFAB-C149-4AFF-9BA5-E919E2B8ADADQ28282376-3B0EEADC-B72C-4984-96B2-1B37DD9F7850Q33206221-3E529D45-B6C4-4C2C-AC7D-9ABAB132FA2DQ33233245-FDD9D4FA-8F8F-4845-92E9-BC9674969F5EQ33267067-B8FE1201-E27A-449B-85A7-1A095AFEB6ECQ33787531-A208F331-949B-42D5-9A35-DB6754690449Q33852071-CAA203D3-7CA6-4A9E-B836-07CC3A6787A3Q33883722-880397C9-FA5B-4B72-8101-5BEBE7C70E28Q33918275-5DDCF549-EC79-4223-B380-FE2AC98F9B58Q34208672-B10DBD5C-AC14-4853-B87F-DDE66191E936Q34223779-0934E027-0D90-46F2-9795-634FDA182D04Q34362568-9AED6F28-CB01-4F02-BE53-9F091C597F92Q34364620-9C625F20-CEB8-4414-804E-6F2050F54205Q34719476-F255925B-9A0D-4B10-BDD0-E3CD25F5EFD6Q35050618-D668B687-CAC4-4ECC-BDC6-A84DC5B96DCDQ35185125-65A47EE2-C80E-4556-A7D6-5F1D10A30258Q35259824-DD0C653E-DCE9-426B-85B5-7BD6D9C9EDD3Q35359369-9EBD3663-9709-40B5-9FCC-9305761EBE1FQ35635522-9CF73E09-9DEA-4F0F-B026-78A3C0D33DA8Q35721334-75D6209C-CCBC-4B86-92FE-BCF237257E66Q35858997-BD51B06D-0F65-45EA-9BBC-CBEDB8765E56Q35964745-8039356A-C9D2-470D-AFCE-56851CB8E6C2Q36007344-2D00427E-9951-4B92-8958-9C0402E824CDQ36153966-7D4A9124-E86B-4172-BF04-BF9EA13AC6B7Q36304057-8FC9878D-D114-43F2-953E-42DB06C9B6F1Q36327100-2B6006C7-BE4A-4B61-B56E-F3970EC949A1Q36442537-48A27061-AF7F-4081-AF6A-440F5EED5663Q36447557-29DAF66D-10CC-4046-8066-EA77BAE4FDB3Q36467514-908C5C0F-12FA-4694-BA01-2F53C32899D3Q36502057-C4CC4333-35E6-46A8-9FFB-6C8FF6A69AAAQ36505790-DB22E6FE-3087-4E0D-95E5-07868DF6B08BQ36607394-D0B28982-4D06-434F-9A9E-52A2F08F2F99Q36652077-DBB4A51A-EE24-4EC0-89CD-A82F1DA1F991Q36698116-C2ED6049-D1AC-402E-BCB7-F0D8BF0CF8ECQ36849343-C0695E9B-1E58-46CD-97D7-8560263C03EEQ36954038-B4AC4B40-2A78-4BF1-832A-A4C4757116ECQ36980718-573FFFA6-AD05-40C8-B4AA-76DF7BD18419
P2860
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Selection of a hepatitis B vir ...... liver transplantation patient.
@en
Selection of a hepatitis B vir ...... liver transplantation patient.
@nl
type
label
Selection of a hepatitis B vir ...... liver transplantation patient.
@en
Selection of a hepatitis B vir ...... liver transplantation patient.
@nl
prefLabel
Selection of a hepatitis B vir ...... liver transplantation patient.
@en
Selection of a hepatitis B vir ...... liver transplantation patient.
@nl
P2093
P1476
Selection of a hepatitis B vir ...... liver transplantation patient
@en
P2093
Bettina Werle
Carol L Brosgart
Christian Trépo
Christopher Westland
Craig S Gibbs
David Durantel
Jean-Pierre Villeneuve
Parviz Parvaz
Sandra Durantel
Shelly Xiong
P304
P356
10.1016/J.JHEP.2003.09.022
P577
2003-12-01T00:00:00Z